{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T04:37:32Z","timestamp":1772771852633,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T00:00:00Z","timestamp":1562630400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T00:00:00Z","timestamp":1562630400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12917-019-1980-z","type":"journal-article","created":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T14:14:22Z","timestamp":1562681662000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Effect of Pimobendan on NT-proBNP and c troponin I before and after a submaximal exercise test in dogs with preclinical mitral valve disease without cardiomegaly \u2013 a randomised, double-blinded trial"],"prefix":"10.1186","volume":"15","author":[{"given":"Nayeli","family":"Iwanuk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4577-3739","authenticated-orcid":false,"given":"Ingo","family":"Nolte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leona","family":"Wall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maximiliane","family":"Sehn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Raue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Pilgram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja","family":"Rumstedt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan-Peter","family":"Bach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,9]]},"reference":[{"issue":"4","key":"1980_CR1","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/MCA.0b013e328338cd1f","volume":"21","author":"V Singh","year":"2010","unstructured":"Singh V, Martinezclark P, Pascual M, Shaw ES, O'neill WW. Cardiac biomarkers\u2013the old and the new: a review. Coron Artery Dis. 2010;21(4):244\u201356.","journal-title":"Coron Artery Dis"},{"issue":"1008","key":"1980_CR2","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1136\/pgmj.2008.073759","volume":"85","author":"V Puntmann","year":"2009","unstructured":"Puntmann V. How-to guide on biomarkers: biomarker definitions, validation and applications with examples from cardiovascular disease. Postrgr Med J. 2009;85(1008):538\u201345.","journal-title":"Postrgr Med J"},{"issue":"6","key":"1980_CR3","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.cvsm.2013.07.010","volume":"43","author":"MA Oyama","year":"2013","unstructured":"Oyama MA. Using cardiac biomarkers in veterinary practice. Vet Clin North Am Small Anim Pract. 2013;43(6):1261\u201372 vi.","journal-title":"Vet Clin North Am Small Anim Pract"},{"issue":"10","key":"1980_CR4","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.2460\/javma.232.10.1496","volume":"232","author":"MA Oyama","year":"2008","unstructured":"Oyama MA, Fox PR, Rush JE, Rozanski EA, Lesser M. Clinical utility of serum N-terminal pro-B-type natriuretic peptide concentration for identifying cardiac disease in dogs and assessing disease severity. J Am Vet Med Assoc. 2008;232(10):1496\u2013503.","journal-title":"J Am Vet Med Assoc"},{"issue":"2","key":"1980_CR5","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/vcp.12044","volume":"42","author":"J Wolf","year":"2013","unstructured":"Wolf J, Gerlach N, Weber K, Klima A, Wess G. The diagnostic relevance of NT-proBNP and proANP 31-67 measurements in staging of myxomatous mitral valve disease in dogs. Vet Clin Pathol. 2013;42(2):196\u2013206.","journal-title":"Vet Clin Pathol"},{"issue":"3","key":"1980_CR6","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.ejheart.2003.12.015","volume":"6","author":"C Hall","year":"2004","unstructured":"Hall C. Essential biochemistry and physiology of (NT-pro)BNP. Eur J Heart Fail. 2004;6(3):257\u201360.","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"1980_CR7","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1136\/hrt.2005.071233","volume":"92","author":"M Weber","year":"2006","unstructured":"Weber M, Hamm C. Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine. Heart. 2006;92(6):843\u20139.","journal-title":"Heart."},{"issue":"5","key":"1980_CR8","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1111\/j.1939-1676.2009.0347.x","volume":"23","author":"V Chetboul","year":"2009","unstructured":"Chetboul V, Serres F, Tissier R, Lefebvre H, Sampedrano CC, Gouni V, et al. Association of plasma N-terminal pro-B-type natriuretic peptide concentration with mitral regurgitation severity and outcome in dogs with asymptomatic degenerative mitral valve disease. J Vet Intern Med. 2009;23(5):984\u201394.","journal-title":"J Vet Intern Med"},{"issue":"3","key":"1980_CR9","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/j.1476-4431.2008.00307.x","volume":"18","author":"SM Wells","year":"2008","unstructured":"Wells SM, Sleeper M. Cardiac troponins. J Vet Em Crit Care. 2008;18(3):235\u201345.","journal-title":"J Vet Em Crit Care"},{"key":"1980_CR10","doi-asserted-by":"publisher","first-page":"786","DOI":"10.7326\/0003-4819-142-9-200505030-00015","volume":"142","author":"A Jeremias","year":"2005","unstructured":"Jeremias A, Gibson CM. Narrative review: alternative causes for elevated cardiac troponin levels when acute coronary syndromes are excluded. Ann Intern Med. 2005;142:786\u201391.","journal-title":"Ann Intern Med"},{"issue":"10","key":"1980_CR11","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/j.1751-0813.2008.00345.x","volume":"86","author":"F Porciello","year":"2008","unstructured":"Porciello F, Rishniw M, Herndon WE, Birettoni F, Antognoni MT, Simpson KW. Cardiac troponin I is elevated in dogs and cats with azotaemia renal failure and in dogs with non-cardiac systemic disease. Aust Vet J. 2008;86(10):390\u20134.","journal-title":"Aust Vet J"},{"issue":"2","key":"1980_CR12","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/CVM-2-2-075","volume":"2","author":"BU Goldmann","year":"2001","unstructured":"Goldmann BU, Christenson RH, Hamm CW, Meinertz T, Ohman EM. Implications of troponin testing in clinical medicine. Trials. 2001;2(2):75.","journal-title":"Trials"},{"issue":"10","key":"1980_CR13","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/S0022-2828(87)80572-2","volume":"19","author":"B Cummins","year":"1987","unstructured":"Cummins B, Cummins P. Cardiac specific troponin-I release in canine experimental myocardial infarction: development of a sensitive enzyme-linked immunoassay. J Mol Cell Cardiol. 1987;19(10):999\u20131010.","journal-title":"J Mol Cell Cardiol"},{"issue":"6","key":"1980_CR14","doi-asserted-by":"publisher","first-page":"e0199023","DOI":"10.1371\/journal.pone.0199023","volume":"13","author":"L Wall","year":"2018","unstructured":"Wall L, Mohr A, Ripoli FL, Schulze N, Penter CD, Hungerbuehler S, et al. Clinical use of submaximal treadmill exercise testing and assessments of cardiac biomarkers NT-proBNP and cTnI in dogs with presymptomatic mitral regurgitation. PLoS One. 2018;13(6):e0199023.","journal-title":"PLoS One"},{"issue":"24","key":"1980_CR15","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1093\/eurheartj\/eht345","volume":"35","author":"J Magne","year":"2013","unstructured":"Magne J, Mahjoub H, Dulgheru R, Pibarot P, Pierard LA, Lancellotti P. Left ventricular contractile reserve in asymptomatic primary mitral regurgitation. Europ H J. 2013;35(24):1608\u201316.","journal-title":"Europ H J"},{"issue":"11","key":"1980_CR16","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1093\/eurjhf\/hfs114","volume":"14","author":"J Magne","year":"2012","unstructured":"Magne J, Mahjoub H, Pibarot P, Pirlet C, Pierard LA, Lancellotti P. Prognostic importance of exercise brain natriuretic peptide in asymptomatic degenerative mitral regurgitation. Eur J Heart Fail. 2012;14(11):1293\u2013302.","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"1980_CR17","doi-asserted-by":"publisher","first-page":"797","DOI":"10.14740\/jocmr2680w","volume":"8","author":"SK Sinha","year":"2016","unstructured":"Sinha SK, Garg S, Thakur R, Krishna V, Singh K, Sachan M, et al. Prognostic importance of exercise brain natriuretic peptide in asymptomatic chronic organic severe mitral regurgitation: an observational study. J Clin Med Res. 2016;8(11):797\u2013804.","journal-title":"J Clin Med Res"},{"issue":"6","key":"1980_CR18","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1111\/jvim.14586","volume":"30","author":"A Boswood","year":"2016","unstructured":"Boswood A, Haggstrom J, Gordon SG, Wess G, Stepien RL, Oyama MA, et al. Effect of Pimobendan in dogs with preclinical Myxomatous mitral valve disease and cardiomegaly: the EPIC study-a randomized clinical trial. J Vet Intern Med. 2016;30(6):1765\u201379.","journal-title":"J Vet Intern Med"},{"issue":"1","key":"1980_CR19","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/jvim.14885","volume":"32","author":"A Boswood","year":"2018","unstructured":"Boswood A, Gordon S, H\u00e4ggstr\u00f6m J, Wess G, Stepien R, Oyama M, et al. Longitudinal analysis of quality of life, clinical, radiographic, echocardiographic, and laboratory variables in dogs with preclinical Myxomatous mitral valve disease receiving Pimobendan or placebo: the EPIC study. J Vet Intern Med. 2018;32(1):72\u201385.","journal-title":"J Vet Intern Med"},{"issue":"1","key":"1980_CR20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1385\/CT:5:1:043","volume":"5","author":"R Tissier","year":"2005","unstructured":"Tissier R, Chetboul V, Moraillon R, Nicolle A, Carlos C, Enriquez B, et al. Increased mitral valve regurgitation and myocardial hypertrophy in two dogs with long-term pimobendan therapy. Cardiovasc Toxicol. 2005;5(1):43\u201351.","journal-title":"Cardiovasc Toxicol"},{"issue":"4","key":"1980_CR21","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1111\/j.1939-1676.2007.tb03016.x","volume":"21","author":"V Chetboul","year":"2007","unstructured":"Chetboul V, Lefebvre HP, Sampedrano CC, Gouni V, Saponaro V, Serres F, et al. Comparative adverse cardiac effects of pimobendan and benazepril monotherapy in dogs with mild degenerative mitral valve disease: a prospective, controlled, blinded, and randomized study. J Vet Intern Med. 2007;21(4):742\u201353.","journal-title":"J Vet Intern Med"},{"issue":"6","key":"1980_CR22","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1111\/j.1939-1676.2009.0392.x","volume":"23","author":"C Atkins","year":"2009","unstructured":"Atkins C, Bonagura J, Ettinger S, Fox P, Gordon S, Haggstrom J, et al. Guidelines for the diagnosis and treatment of canine chronic valvular heart disease. J Vet Intern Med. 2009;23(6):1142\u201350.","journal-title":"J Vet Intern Med"},{"issue":"4","key":"1980_CR23","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1111\/j.1939-165X.2012.00467.x","volume":"41","author":"P Silvestrini","year":"2012","unstructured":"Silvestrini P, Piviani M, Alberola J, Rodr\u00edguez-Cort\u00e9s A, Planellas M, Roura X, et al. Serum cardiac troponin I concentrations in dogs with leishmaniasis: correlation with age and clinicopathologic abnormalities. Vet Clin Pathol. 2012;41(4):568\u201374.","journal-title":"Vet Clin Pathol"},{"issue":"6","key":"1980_CR24","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1111\/j.1740-8261.2002.tb01051.x","volume":"43","author":"K Hansson","year":"2002","unstructured":"Hansson K, H\u00e4ggstr\u00f6m J, Kvart C, Lord P. Left atrial to aortic root indices using two-dimensional and M-mode echocardiography in cavalier king Charles spaniels with and without left atrial enlargement. Veterinary Radiology & Ultrasound. 2002;43(6):568\u201375.","journal-title":"Veterinary Radiology & Ultrasound"},{"issue":"3","key":"1980_CR25","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/j.1939-1676.2004.tb02551.x","volume":"18","author":"CC Cornell","year":"2004","unstructured":"Cornell CC, Kittleson MD, Torre PD, H\u00e4ggstr\u00f6m J, Lombard CW, Pedersen HD, et al. Allometric scaling of M-mode cardiac measurements in normal adult dogs. J Vet Intern Med. 2004;18(3):311\u201321.","journal-title":"J Vet Intern Med"},{"issue":"1","key":"1980_CR26","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/jvim.12472","volume":"29","author":"PR Fox","year":"2015","unstructured":"Fox PR, Oyama MA, Hezzell MJ, Rush JE, Nguyenba TP, DeFrancesco TC, et al. Relationship of plasma N-terminal pro-brain natriuretic peptide concentrations to heart failure classification and cause of respiratory distress in dogs using a 2nd generation ELISA assay. J Vet Intern Med. 2015;29(1):171\u20139.","journal-title":"J Vet Intern Med"},{"key":"1980_CR27","first-page":"S1","volume":"14","author":"W Diederen","year":"1989","unstructured":"Diederen W. Hemodynamic profile of the cardiotonic agent pimobendan. J Cardiovasc Pharmacol. 1989;14:S1\u20136.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"4","key":"1980_CR28","first-page":"360","volume":"29","author":"H Scheld","year":"1989","unstructured":"Scheld H, Fritsche R, Schlepper M, Meel J. Pimobendan increases calcium sensitivity of skinned human papillary muscle fibers. J Clin Pharm Ther. 1989;29(4):360\u20135.","journal-title":"J Clin Pharm Ther"},{"issue":"5","key":"1980_CR29","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/BF00167264","volume":"339","author":"D Brunkhorst","year":"1989","unstructured":"Brunkhorst D, Hv d L, Meyer W, Nigbur R, Schmidt-Schumacher C, Scholz H. Relation of positive inotropic and chronotropic effects of pimobendan, UD-CG 212 cl, milrinone and other phosphodiesterase inhibitors to phosphodiesterase III inhibition in Guinea-pig heart. Naunyn Schmiedeberg's Arch Pharmacol. 1989;339(5):575\u201383.","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"1980_CR30","doi-asserted-by":"publisher","first-page":"S93","DOI":"10.1016\/j.jvc.2009.03.003","volume":"11","author":"H Kellihan","year":"2009","unstructured":"Kellihan H, Oyama M, Reynolds C, Stepien R. Weekly variability of plasma and serum NT-proBNP measurements in normal dogs. J Vet Cardiol. 2009;11:S93\u2013S7.","journal-title":"J Vet Cardiol"},{"issue":"5","key":"1980_CR31","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1111\/j.1939-1676.2008.0150.x","volume":"22","author":"J H\u00e4ggstr\u00f6m","year":"2008","unstructured":"H\u00e4ggstr\u00f6m J, Boswood A, O'grady M, J\u00f6ns O, Smith S, Swift S, et al. Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: the QUEST study. J Vet Intern Med. 2008;22(5):1124\u201335.","journal-title":"J Vet Intern Med"},{"issue":"6","key":"1980_CR32","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1111\/jvim.12181","volume":"27","author":"J H\u00e4ggstr\u00f6m","year":"2013","unstructured":"H\u00e4ggstr\u00f6m J, Boswood A, O'Grady M, J\u00f6ns O, Smith S, Swift S, et al. Longitudinal analysis of quality of life, clinical, radiographic, echocardiographic, and laboratory variables in dogs with myxomatous mitral valve disease receiving pimobendan or benazepril: the QUEST study. J Vet Intern Med. 2013;27(6):1441\u201351.","journal-title":"J Vet Intern Med"},{"issue":"6","key":"1980_CR33","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.ahj.2005.01.051","volume":"150","author":"J Scharhag","year":"2005","unstructured":"Scharhag J, Herrmann M, Urhausen A, Haschke M, Herrmann W, Kindermann W. Independent elevations of N-terminal pro-brain natriuretic peptide and cardiac troponins in endurance athletes after prolonged strenuous exercise. Am Heart J. 2005;150(6):1128\u201334.","journal-title":"Am Heart J"},{"issue":"8","key":"1980_CR34","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1249\/MSS.0b013e318172cf22","volume":"40","author":"J Scharhag","year":"2008","unstructured":"Scharhag J, George K, Shave R, Urhausen A, Kindermann W. Exercise-associated increases in cardiac biomarkers. Med Sci Sports Exerc. 2008;40(8):1408\u201315.","journal-title":"Med Sci Sports Exerc"},{"issue":"4","key":"1980_CR35","doi-asserted-by":"crossref","first-page":"625","DOI":"10.33549\/physiolres.931773","volume":"59","author":"J Krupicka","year":"2010","unstructured":"Krupicka J, Janota T, Kasalova Z, Hradec J. Effect of short-term maximal exercise on BNP plasma levels in healthy individuals. Physiol Res. 2010;59(4):625.","journal-title":"Physiol Res"}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-019-1980-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12917-019-1980-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-019-1980-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T10:07:33Z","timestamp":1663927653000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcvetres.biomedcentral.com\/articles\/10.1186\/s12917-019-1980-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,9]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1980"],"URL":"https:\/\/doi.org\/10.1186\/s12917-019-1980-z","relation":{},"ISSN":["1746-6148"],"issn-type":[{"value":"1746-6148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,9]]},"assertion":[{"value":"26 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by an ethical review committee (Lower Saxony State Office for Consumer Protection and Food Safety (LAVES), 33.9\u201342502-05-14A484) and written consent from the dog owners was obtained.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Publication of the dogs\u2019 data in anonymised form was approved by all owners.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"237"}}